Changes in urinary excretion of helical peptide during therapy for osteoporosis in older adults.
Taxel
Pamela
P
Division of Endocrinology and Metabolism, University of Connecticut Health Center, Farmington, CT, USA. taxel@nso.uchc.edu
Fall
Pamela M
PM
Prestwood
Karen M
KM
Dulipsingh
Lahta
L
Dauser
Debrorah
D
Ohannessian
Christine
C
Raisz
Lawrence G
LG
D000368:Aged; D000596:Amino Acids / Q000652:urine*; D015415:Biomarkers / Q000652:urine; D003094:Collagen / Q000652:urine*; D024042:Collagen Type I / Q000652:urine*; D005260:Female; D006801:Humans; D007118:Immunoassay / Q000379:methods; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy* / Q000652:urine*; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000652:urine; D010455:Peptides / Q000652:urine*; D016032:Randomized Controlled Trials as Topic
D000596:Amino Acids; D015415:Biomarkers; D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; C036020:deoxypyridinoline; D003094:Collagen